全文获取类型
收费全文 | 1464篇 |
免费 | 103篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 60篇 |
妇产科学 | 31篇 |
基础医学 | 151篇 |
口腔科学 | 19篇 |
临床医学 | 166篇 |
内科学 | 325篇 |
皮肤病学 | 40篇 |
神经病学 | 134篇 |
特种医学 | 17篇 |
外科学 | 225篇 |
综合类 | 9篇 |
一般理论 | 7篇 |
预防医学 | 173篇 |
眼科学 | 43篇 |
药学 | 66篇 |
中国医学 | 1篇 |
肿瘤学 | 104篇 |
出版年
2022年 | 8篇 |
2021年 | 21篇 |
2020年 | 13篇 |
2019年 | 26篇 |
2018年 | 32篇 |
2017年 | 15篇 |
2016年 | 26篇 |
2015年 | 43篇 |
2014年 | 63篇 |
2013年 | 78篇 |
2012年 | 89篇 |
2011年 | 115篇 |
2010年 | 59篇 |
2009年 | 64篇 |
2008年 | 78篇 |
2007年 | 75篇 |
2006年 | 92篇 |
2005年 | 89篇 |
2004年 | 78篇 |
2003年 | 82篇 |
2002年 | 65篇 |
2001年 | 28篇 |
2000年 | 44篇 |
1999年 | 22篇 |
1998年 | 16篇 |
1997年 | 7篇 |
1996年 | 10篇 |
1995年 | 6篇 |
1994年 | 5篇 |
1993年 | 10篇 |
1992年 | 13篇 |
1991年 | 8篇 |
1990年 | 12篇 |
1989年 | 12篇 |
1988年 | 10篇 |
1987年 | 17篇 |
1986年 | 12篇 |
1985年 | 6篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1982年 | 12篇 |
1981年 | 11篇 |
1980年 | 7篇 |
1976年 | 8篇 |
1974年 | 3篇 |
1927年 | 5篇 |
1926年 | 5篇 |
1924年 | 6篇 |
1922年 | 2篇 |
1921年 | 2篇 |
排序方式: 共有1574条查询结果,搜索用时 15 毫秒
1.
Clinical Spectrum of Capillary Malformation–Arteriovenous Malformation Syndrome Presenting to a Pediatric Dermatology Practice: A Retrospective Study
下载免费PDF全文
![点击此处可从《Pediatric dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Nicole A. Weitz M.D. Christine T. Lauren M.D. Gerald G. Behr M.D. June K. Wu M.D. Jessica J. Kandel M.D. Philip M. Meyers M.D. Sally Sultan M.D. Kwame Anyane‐Yeboa M.D. Kimberly D. Morel M.D. Maria C. Garzon M.D. 《Pediatric dermatology》2015,32(1):76-84
Capillary malformation–arteriovenous malformation syndrome (CM‐AVM) is an autosomal dominant disorder caused by RASA1 mutations. The prevalence and phenotypic spectrum are unknown. Evaluation of patients with multiple CMs is challenging because associated AVMs can be life threatening. The objective of this study was to describe the clinical characteristics of children presenting with features of CM‐AVM to an academic pediatric dermatology practice. After institutional review board approval was received, a retrospective chart review was performed of patients presenting between 2009 and 2012 with features of CM‐AVM. We report nine cases. Presenting symptoms ranged from extensive vascular stains and cardiac failure to CMs noted incidentally during routine skin examination. All demonstrated multiple CMs, two had Parkes Weber syndrome, and two had multiple infantile hemangiomas. Seven patients had family histories of multiple CMs; three had family histories of large, atypical CMs. Six had personal or family histories of AVMs. Genetic evaluation was recommended for all and was pursued by six families; four RASA1 mutations were identified, including one de novo. Consultations with neurology, cardiology, and orthopedics were recommended. Most patients (89%) have not required treatment to date. CM‐AVM is an underrecognized condition with a wide clinical spectrum that often presents in childhood. Further evaluation may be indicated in patients with multiple CMs. This study is limited by its small and retrospective nature. 相似文献
2.
Prof. Wilh Weitz 《Journal of molecular medicine (Berlin, Germany)》1925,4(4):162-164
Ohne Zusammenfassung 相似文献
3.
Ilene Fennoy 《Journal of the National Medical Association》1981,73(4):313-316
Many risk factors have been identified with the progression of atherosclerotic lesions. Of these hyperglycemia, hypertension, hyperlipidemia, and obesity are amenable to nutritional therapy. Minimal data exist to prove that alteration in these risk factors prevent atherosclerosis in adults and children. This paper discusses nutritional approaches to prevention of atherosclerosis in children. 相似文献
4.
5.
Blood flow distribution and its temporal variability in stimulated dog gastrocnemius muscle 总被引:2,自引:0,他引:2
C Marconi N Heisler M Meyer H Weitz D R Pendergast P Cerretelli J Piiper 《Respiration physiology》1988,74(1):1-13
The distribution of blood flow in skeletal muscle stimulated to rhythmic isotonic contractions was studied by injections of radioactive microspheres into the arterial supply in 8 gastrocnemius muscles (mean weight 84 g) of 6 anesthetized dogs (20-25 kg body weight). The distribution of 10 micron microspheres in regions of about 0.5 g was very similar to that of the standard 15 micron microspheres, whereas that of 25 micron microspheres was more uneven. The coefficient of variation (CV = SD/mean) of the ratio of simultaneously injected 10 micron and 15 micron microspheres, 0.12, was taken as the inherent scatter of the method. The average spatial distribution inequality of 10-15 micron microspheres corresponded to a CV of 0.45 and the specific local blood flow inhomogeneity to a CV = 0.43 ( = square root 0.45(2) - 0.12(2], but there were marked differences between muscles. At equal blood flow levels, the inhomogeneity during reactive hyperemia was similar to that observed during stimulation. The temporal variability of blood flow in individual muscle pieces was obtained from the comparison of fractional trapping of 4 to 5 differently labeled microspheres injected at intervals of 2 min into steadily stimulated muscles. The mean CV for the variations in time was 0.23 and that corrected for methodological scatter, 0.19, but the differences in the extent of temporal blood flow changes among muscle pieces within a muscle and between different muscles were large. The presence of considerable spatial and temporal variations of blood flow in exercising muscle during apparent steady state may be important in limiting and/or modulating tissue O2 supply. 相似文献
6.
H A Liebman M K Carfagno I C Weitz P Berard J M Diiorio E Vosburgh R W Simms 《American journal of clinical pathology》1992,98(5):534-541
Severe bleeding resulting from excessive fibrinolysis has been observed in patients with primary amyloidosis. The authors studied a patient with this hemostatic disorder before and during therapy with epsilon-aminocaproic acid. Excessive fibrinolysis was associated with depressed plasma concentrations of coagulation Factors XII, XI, high-molecular-weight kininogen, and Factors VIII and V; and plasminogen and alpha-2-plasmin inhibitor. These deficiencies were corrected with treatment. The functional and antigenic concentrations of tissue plasminogen activator and plasminogen activator inhibitor in the patient's plasma were normal. Urokinase-type activator activity and antigen were three to five times elevated in the patient's plasma. Results of immunoprecipitation showed that single-chain urokinase-type activator was the primary urokinase-type activator species in the patient's plasma. Excessive fibrinolysis in patients with amyloidosis results from increased plasma single-chain urokinase-type activator activity. 相似文献
7.
Ikwunga Wonodi Gloria Reeves Dana Carmichael Ilene Verovsky Matthew T Avila Amie Elliott L Elliot Hong Helene M Adami Gunvant K Thaker 《Movement disorders》2007,22(12):1777-1782
Recent years have witnessed increased antipsychotic treatment of children despite limited long‐term safety data in children. In this study, motor side effects associated with the use of antipsychotic drugs in children were examined in a sample of pediatric psychiatric patients. Child and adolescent psychiatric patients receiving antipsychotics (most were on atypicals) for 6 months or longer (n = 118) were compared with antipsychotic‐naïve patients (n = 80) with similar age, sex ratio, and diagnoses. Only 19% of patients on antipsychotics had ever experienced psychotic symptoms. Eleven children (9%) on antipsychotics exhibited dyskinesia, when compared with 0 in the naïve group (P = 0.003, Fisher's exact test). Nine of 62 African–American children (15%) on antipsychotics exhibited dyskinesia, when compared with only 4% (2 of 52) of European–American children (P = 0.003, Fisher's exact test). Children treated with antipsychotic drugs might experience a significant risk of dyskinesia even when treated only with atypical antipsychotics. Ethnicity might also be a risk factor for dyskinesia in children. Side‐effect profile of the atypical antipsychotic drugs in children may be much different than that in adults. © 2007 Movement Disorder Society 相似文献
8.
9.
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism 总被引:30,自引:0,他引:30
Kearon C Gent M Hirsh J Weitz J Kovacs MJ Anderson DR Turpie AG Green D Ginsberg JS Wells P MacKinnon B Julian JA 《The New England journal of medicine》1999,340(12):901-907
BACKGROUND: Patients who have a first episode of venous thromboembolism in the absence of known risk factors for thrombosis (idiopathic thrombosis) are often treated with anticoagulant therapy for three months. Such patients may benefit from longer treatment, however, because they appear to have an increased risk of recurrence after anticoagulant therapy is stopped. METHODS: In this double-blind study, we randomly assigned patients who had completed 3 months of anticoagulant therapy for a first episode of idiopathic venous thromboembolism to continue receiving warfarin, with the dose adjusted to achieve an international normalized ratio of 2.0 to 3.0, or to receive placebo for a further 24 months. Our goal was to determine the effects of extended anticoagulant therapy on rates of recurrent symptomatic venous thromboembolism and bleeding. RESULTS: A prespecified interim analysis of efficacy led to the early termination of the trial after 162 patients had been enrolled and followed for an average of 10 months. Of 83 patients assigned to continue to receive placebo, 17 had a recurrent episode of venous thromboembolism (27.4 percent per patient-year), as compared with 1 of 79 patients assigned to receive warfarin (1.3 percent per patient-year, P<0.001). Warfarin resulted in a 95 percent reduction in the risk of recurrent venous thromboembolism (95 percent confidence interval, 63 to 99 percent). Three patients assigned to the warfarin group had nonfatal major bleeding (two had gastrointestinal bleeding and one genitourinary bleeding), as compared with none of those assigned to the placebo group (3.8 vs. 0 percent per patient-year, P=0.09). CONCLUSIONS: Patients with a first episode of idiopathic venous thromboembolism should be treated with anticoagulant agents for longer than three months. 相似文献
10.
Expression of CD138 (Syndecan-1) in renal cell carcinoma is reduced with increasing nuclear grade. 总被引:1,自引:0,他引:1
Neriman G?kden Graham F Greene Ilene B Bayer-Garner Horace J Spencer Ralph D Sanderson Murat G?kden 《Applied immunohistochemistry & molecular morphology》2006,14(2):173-177
CD138/Syndecan-1 is a cell-surface heparan sulfate proteoglycan expressed on most epithelial cells, and decreased CD138 expression is associated with increased invasive and metastatic potential in carcinomas. CD138 expression has not been investigated previously in renal neoplasms. Formalin-fixed, paraffin-embedded tissue sections of 50 renal cell carcinomas (RCCs) (40 clear-cell RCCs of various nuclear grades, 10 of which harbored metastases; 6 papillary RCCs, 4 chromophobe RCCs) and 4 oncocytomas were stained immunohistochemically for CD138 using the monoclonal antibody B-B4 (CD138). Staining intensity and distribution were scored and results related to histologic type, nuclear grade, and local stage (pT). Immunoreactivity was membranous in all clear-cell RCCs, chromophobe RCCs, and oncocytomas and was located at the basal aspect of cytoplasm in papillary RCCs. In clear-cell RCCs, the extent of CD138 immunoreactivity decreased with increasing nuclear grade (P<0.001). No significant correlation was found between CD138 immunoreactivity and histologic type (P=0.2) or local stage (P=0.7). Metastatic foci showed a mild to moderate decrease in intensity compared with primary tumor. Decreased expression of CD138 may have a role in more aggressive behavior of clear-cell RCC. 相似文献